Clinical Trials Logo

Feeding and Eating Disorders clinical trials

View clinical trials related to Feeding and Eating Disorders.

Filter by:

NCT ID: NCT02568007 Terminated - Feeding Behaviors Clinical Trials

Effects of Cyproheptadine on Growth and Behavior in Pediatric Feeding Disorders

Start date: December 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to examine the effect of standard dosing of cyproheptadine for both cycled and continuous administration, as compared to no medication, on appetite stimulation and growth in the pediatric gastroenterology feeding team patient population. The secondary aim is to evaluate the effect, if any, of the suspected tachyphylaxis that is commonly associated with cyproheptadine use. The third aim will be to examine the type and duration of side effects of cyproheptadine in this population. The ultimate goal will be to create a standardized protocol for cyproheptadine therapy in children with feeding disorders and suboptimal growth.

NCT ID: NCT02567890 Completed - Eating Disorders Clinical Trials

Swedish Body Project for Prevention of Eating Disorders

sBodyProject
Start date: September 2015
Phase: N/A
Study type: Interventional

Women in general and young girls in particular are constantly exposed to unhealthy body and appearance ideals through media that contribute to body dissatisfaction and unhealthy behaviors such as rigid dieting, which in interaction with genes and other factors increase the risk of developing eating disorders such as anorexia nervosa and bulimia nervosa. The investigators aim is to investigate the extent to which an interactive prevention program, delivered through Internet, called the Swedish Body Project (sBody Project) can decrease the emergence of eating disorders among young females. The sBody Project is based on a "Dissonance-Based Intervention: (DBI)" that has shown very promising results. The adaptations and changes in the format of delivery accomplished in this study might help to disseminate the program on a broad basis, and consequently affect the health of young females on a much larger scale the ever before.

NCT ID: NCT02564588 Completed - Clinical trials for Binge Eating Disorder

Dasotraline Binge Eating Disorder Study

Start date: October 2015
Phase: Phase 2/Phase 3
Study type: Interventional

Evaluate the efficacy of flexibly-dosed dasotraline compared with placebo in adults with moderate to severe Binge Eating Disorder (BED)

NCT ID: NCT02555553 Completed - Clinical trials for Binge Eating Disorder

Noom Monitor for Binge Eating

Start date: April 2016
Phase: N/A
Study type: Interventional

The purpose of the proposed Phase II STTR study is to test the primary efficacy of a novel mobile app, 'Noom Monitor,' in a large population of binge eaters in the Kaiser Permanente health care system relative to a well-established treatment as usual (TAU) control condition. Noom Monitor facilitates the delivery of CBT-GSH by utilizing a patient interface that increases adherence and provides between-session reminders of CBT-GSH principles. In addition, the Noom Monitor includes a therapist interface with weekly feedback to the provider about patient progress. This application has several primary objectives, including: (1) testing the real-world effectiveness of the Noom Monitor in a clinical setting, and (2) establishing a database of training materials for Noom Monitor. The knowledge gained from the current study will contribute to our understanding of the role of new emerging mobile technologies in augmenting existing treatments.

NCT ID: NCT02553824 Completed - Bulimia Nervosa Clinical Trials

FDA Approved Medication to Reduce Binge Eating and/or Purging

Start date: October 30, 2015
Phase: Phase 1
Study type: Interventional

This study will demonstrate the efficacy of Qsymia versus placebo in treating bulimia nervosa and binge eating disorder.

NCT ID: NCT02535780 Terminated - Anorexia Nervosa Clinical Trials

Transcranial Treatments in Eating Disorders

Start date: August 2015
Phase: N/A
Study type: Interventional

The primary aim of this study is to study how Repetitive Transcranial Magnetic Stimulation (rTMS) tailored to specific anorexia nervosa (AN) or bulimia nervosa (BN) brain activation alterations will promote recovery and to study how inhibitory tDCS (Transcranial Direct Current Stimulation) will reduce symptoms of body image distortion in a second sample of AN and BN groups.

NCT ID: NCT02528409 Completed - Clinical trials for Binge Eating Disorder

Vortioxetine for Binge Eating Disorder

Start date: June 2016
Phase: Phase 2
Study type: Interventional

The aim of the present study is to examine the efficacy and safety of vortioxetine vs placebo in adults with moderate to severe Binge eating disorder, as indicated by at least 3 binge eating days per week for the 2 weeks before the baseline visit.

NCT ID: NCT02503098 Completed - Eating Disorders Clinical Trials

Optimizing a Smartphone Application for Individuals With Eating Disorders

Start date: November 23, 2016
Phase: N/A
Study type: Interventional

This study will augment an existing mobile application for individuals with eating disorders by developing adaptive, tailored content targeting remediation of cognitive distortions. The adaptive application will be deployed and assessed for efficacy relative to the standard product in a randomized controlled trial.

NCT ID: NCT02496637 Completed - Obesity Clinical Trials

A Brief Appetite Awareness Intervention for Eating and Weight Regulation Among College Freshmen

Start date: August 2015
Phase: N/A
Study type: Interventional

The proposed study is a randomized clinical trial investigating the effects of a weight gain and eating dysregulation prevention intervention among college freshmen women. It will compare Appetite Awareness Training (AAT) to a standard nutritional education group and a no treatment control group. Appetite Awareness Training approach to increasing eating regulation through training individuals to eat in response to their appetite cues rather than external or emotional cues.

NCT ID: NCT02495142 Completed - Obesity Clinical Trials

Psychosocial Issues and Bariatric Surgery

LABS3
Start date: July 2010
Phase:
Study type: Observational

Bariatric surgery is associated with long-term weight loss, as well as short-term improvements in obesity-related medical comorbidities. However, a significant proportion of patients fail to lose sufficient weight, or experience significant weight regain. Although no robust predictors of response have been identified, pilot data that will be presented and reviewed suggest that surgery has profound effects on eating behaviors and psychosocial functioning, and that these factors may affect postoperative weight control. The present investigation capitalizes on the Longitudinal Assessment of Bariatric Surgery (LABS) consortium to conduct an in-depth examination of the psychosocial aspects of surgery among a geographically, ethnically, and racially diverse sample of men and women undergoing bariatric surgery. This project unites experts in the areas of psychopathology, eating behaviors and quality of life to conduct a naturalistic study using state-of-the-art assessment tools; to document the relationships among psychosocial factors; and to examine psychosocial predictors of surgical outcomes.